XML 39 R24.htm IDEA: XBRL DOCUMENT
v3.25.3

Joint Ventures | 12 Months Ended
--- | ---
Oct. 03, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Joint Ventures | Joint Ventures The Company’s joint ventures provide services to customers including program management and operations and maintenance services. Joint ventures, the combination of two or more partners, are generally formed for a specific project. Management of the joint venture is typically controlled by a joint venture executive committee, comprised of representatives from the joint venture partners. The joint venture executive committee normally provides management oversight and controls decisions which could have a significant impact on the joint venture. We account for joint ventures in accordance with ASC 810, Consolidation, as discussed in Note 2 — Summary of Significant Accounting Policies. The Company analyzes its joint ventures and classifies them as either: •a VIE that must be consolidated because the Company is the primary beneficiary or the joint venture is not a VIE and the Company holds the majority voting interest with no significant participative rights available to the other partners; or •a VIE that does not require consolidation and is treated as an equity method investment because the Company is not the primary beneficiary or the joint venture is not a VIE and the Company does not hold the majority voting interest. The following table presents selected financial information for our consolidated joint ventures that are VIEs as of October 3, 2025 and September 27, 2024:
| As of
(Amounts in millions) | October 3, 2025 |  | September 27, 2024
Cash and cash equivalents | $ | 167 |  |  | $ | 160 |
Current assets | 191 |  |  | 322 |
Non-current assets | — |  |  | 2 |
Total assets | $ | 358 |  |  | $ | 484 |
Current liabilities | $ | 146 |  |  | $ | 190 |
Non-current liabilities | — |  |  | 1 |
Total liabilities | 146 |  |  | 191 |
Total Amentum equity | 153 |  |  | 228 |
Non-controlling interests | 59 |  |  | 65 |
Total equity | 212 |  |  | 293 |
Total liabilities and equity | $ | 358 |  |  | $ | 484 |
The following table presents selected financial information for our consolidated joint ventures that are VIEs for the years ended October 3, 2025, September 27, 2024 and September 29, 2023:
| For the years ended
(Amounts in millions) | October 3, 2025 |  | September 27, 2024 |  | September 29, 2023
Revenues | $ | 1,489 |  |  | $ | 370 |  |  | $ | 334 |
Cost of revenues | (1,371) |  |  | (337) |  |  | (281) |
Net income including non-controlling interests | 108 |  |  | 29 |  |  | 50 |
The Company has an ownership share in approximately 30 active joint ventures that were determined to be VIEs and are accounted for as equity method investments and the Company’s ownership percentages generally range from 25% to 50%. The following table presents selected financial information for our unconsolidated joint ventures, included as equity method investments on the consolidated balance sheets, as of October 3, 2025 and September 27, 2024:
| As of
(Amounts in millions) | October 3, 2025 |  | September 27, 2024
Current assets | $ | 1,120 |  |  | $ | 701 |
Non-current assets | 49 |  |  | 43 |
Total assets | $ | 1,169 |  |  | $ | 744 |
Current liabilities | $ | 740 |  |  | $ | 422 |
Non-current liabilities | 17 |  |  | 16 |
Total liabilities | 757 |  |  | 438 |
Joint ventures' equity | 412 |  |  | 306 |
Total liabilities and joint ventures' equity | $ | 1,169 |  |  | $ | 744 |
The following table presents selected financial information for our equity method investments for the years ended October 3, 2025, September 27, 2024 and September 29, 2023:
| For the years ended
(Amounts in millions) | October 3, 2025 |  | September 27, 2024 |  | September 29, 2023
Revenues | $ | 3,603 |  |  | $ | 2,634 |  |  | $ | 2,373 |
Cost of revenues | (3,357) |  |  | (2,442) |  |  | (2,215) |
Net income including non-controlling interests | 207 |  |  | 183 |  |  | 152 |
Related party receivables due from our equity method investments were $63 million and $37 million as of October 3, 2025 and September 27, 2024, respectively. These receivables are a result of items purchased and services rendered by us on behalf of our equity method investments. We have assessed these receivables as having minimal collection risk based on our historic experience with these joint ventures and our inherent influence through our ownership interest. The related party revenues earned from our equity method investments was $276 million, $126 million and $45 million for the years ended October 3, 2025, September 27, 2024 and September 29, 2023, respectively. Many of our joint ventures only perform on a single contract. The modification or termination of a contract under a joint venture could trigger an impairment in the fair value of our investment in these entities. In the aggregate, our maximum exposure to losses was $196 million related to our equity method investments as of October 3, 2025.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_VariableInterestEntityDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration